Movement Alert｜Twist Bioscience Corp Rises 6.59% in Regular Trading, Revenue Guidance Significantly Exceeds Expectations Boosting Market Confidence

Market Focus08-05

On August 5, Twist Bioscience Corp rose 6.59% in regular trading, trading at $110.92/share, with turnover of $45.24 million.

On the news front, the company recently reported fiscal Q3 results with revenue of $118.4 million, up 23.2% year-over-year, beating analyst estimates of $114.5 million. More critically, the company raised its full-year revenue guidance to $456-$457 million and projected Q4 revenue of $123-$124 million, substantially above the FactSet consensus estimate of $117.4 million. While Q3 EPS of $(0.56) missed the consensus estimate of $(0.51) and marked a swing from year-ago earnings of $0.33 per share, the strong revenue growth momentum and above-consensus forward guidance have continued to bolster investor confidence in the company's business expansion outlook, driving sustained stock price recovery following initial post-earnings selling pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1199243717?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 21:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199243717","market":"us","top_or_hot":-1,"title":"Movement Alert｜Twist Bioscience Corp Rises 6.59% in Regular Trading, Revenue Guidance Significantly Exceeds Expectations Boosting Market Confidence","media":"Market Focus","content":"<p><p>On August 5, Twist Bioscience Corp rose 6.59% in regular trading, trading at $110.92/share, with turnover of $45.24 million.</p><p>On the news front, the company recently reported fiscal Q3 results with revenue of $118.4 million, up 23.2% year-over-year, beating analyst estimates of $114.5 million. More critically, the company raised its full-year revenue guidance to $456-$457 million and projected Q4 revenue of $123-$124 million, substantially above the FactSet consensus estimate of $117.4 million. While Q3 EPS of $(0.56) missed the consensus estimate of $(0.51) and marked a swing from year-ago earnings of $0.33 per share, the strong revenue growth momentum and above-consensus forward guidance have continued to bolster investor confidence in the company's business expansion outlook, driving sustained stock price recovery following initial post-earnings selling pressure.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Twist Bioscience Corp Rises 6.59% in Regular Trading, Revenue Guidance Significantly Exceeds Expectations Boosting Market Confidence</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Twist Bioscience Corp Rises 6.59% in Regular Trading, Revenue Guidance Significantly Exceeds Expectations Boosting Market Confidence\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-05 21:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 5, Twist Bioscience Corp rose 6.59% in regular trading, trading at $110.92/share, with turnover of $45.24 million.</p><p>On the news front, the company recently reported fiscal Q3 results with revenue of $118.4 million, up 23.2% year-over-year, beating analyst estimates of $114.5 million. More critically, the company raised its full-year revenue guidance to $456-$457 million and projected Q4 revenue of $123-$124 million, substantially above the FactSet consensus estimate of $117.4 million. While Q3 EPS of $(0.56) missed the consensus estimate of $(0.51) and marked a swing from year-ago earnings of $0.33 per share, the strong revenue growth momentum and above-consensus forward guidance have continued to bolster investor confidence in the company's business expansion outlook, driving sustained stock price recovery following initial post-earnings selling pressure.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1199243717","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199243717","pubTimestamp":1785937291,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 5, Twist Bioscience Corp rose 6.59% in regular trading, trading at $110.92/share, with turnover of $45.24 million.On the news front, the company recently reported fiscal Q3 results with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"走势提醒|Twist Bioscience Corp常规交易上涨6.59%，营收指引大幅超预期提振市场信心","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"On August 5, Twist Bioscience Corp rose 6.59% in regular trading, trading at $110.92/share, with turnover of $45.24 million.On the news front, the company recently reported fiscal Q3 results with revenue of $118.4 million, up 23.2% year-over-year, beating analyst estimates of $114.5 million. More critically, the company raised its full-year revenue guidance to $456-$457 million and projected Q4 revenue of $123-$124 million, substantially above the FactSet consensus estimate of $117.4 million. While Q3 EPS of $(0.56) missed the consensus estimate of $(0.51) and marked a swing from year-ago earnings of $0.33 per share, the strong revenue growth momentum and above-consensus forward guidance have continued to bolster investor confidence in the company's business expansion outlook, driving sustained stock price recovery following initial post-earnings selling pressure.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1199243717","isCrawlerRequest":true}